AAAAAA
Results:
1-24
|
Results: 24
Authors:
Colpaert, FC
Tarayre, JP
Alliaga, M
Slot, LAB
Attal, N
Koek, W
Citation: Fc. Colpaert et al., Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats, PAIN, 91(1-2), 2001, pp. 33-45
Authors:
Bardin, L
Tarayre, JP
Koek, W
Colpaert, FC
Citation: L. Bardin et al., In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1Areceptor-mediated, behaviorally specific analgesia, EUR J PHARM, 421(2), 2001, pp. 109-114
Authors:
Koek, W
Vacher, B
Cosi, C
Assie, MB
Patoiseau, JF
Pauwels, PJ
Colpaert, FC
Citation: W. Koek et al., 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential, EUR J PHARM, 420(2-3), 2001, pp. 103-112
Authors:
Bergman, J
France, CP
Holtzman, SG
Katz, JL
Koek, W
Stephens, DN
Citation: J. Bergman et al., Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABA(A)-ergic ligands, PSYCHOPHAR, 153(1), 2000, pp. 67-84
Authors:
Koek, W
Assie, MB
Zernig, G
France, CP
Citation: W. Koek et al., In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats, PSYCHOPHAR, 149(4), 2000, pp. 377-387
Authors:
Prinssen, EPM
Koek, W
Colpaert, FC
Kleven, MS
Citation: Epm. Prinssen et al., Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced, BEHAV PHARM, 11(3-4), 2000, pp. 299-305
Authors:
Colpaert, FC
Slot, LAB
Koek, W
Dupuis, DS
Citation: Fc. Colpaert et al., Memory of an operant response and of depressed mood retained in activationstates of 5-HT1A receptors: evidence from rodent models, BEH BRA RES, 117(1-2), 2000, pp. 41-51
Authors:
Assie, MB
Koek, W
Citation: Mb. Assie et W. Koek, Estimation of apparent pA(2) values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats, EUR J PHARM, 409(2), 2000, pp. 173-177
Authors:
Cosi, C
Koek, W
Citation: C. Cosi et W. Koek, The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors, EUR J PHARM, 401(1), 2000, pp. 9-15
Authors:
Prinssen, EPM
Koek, W
Kleven, MS
Citation: Epm. Prinssen et al., Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT1A receptors, EUR J PHARM, 395(2), 2000, pp. 143-147
Authors:
Prinssen, EPM
Koek, W
Kleven, MS
Citation: Epm. Prinssen et al., The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds, EUR J PHARM, 388(1), 2000, pp. 57-67
Authors:
Assie, MB
Koek, W
Citation: Mb. Assie et W. Koek, [H-3]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT1Aand non-5-HT1A receptors, BR J PHARM, 130(6), 2000, pp. 1348-1352
Authors:
Kleven, MS
Kamenka, JM
Vignon, J
Koek, W
Citation: Ms. Kleven et al., Pharmacological characterization of the discriminative stimulus propertiesof the phencyclidine analog, N[1-(2-benzo(b)thiophenyl)-cyclohexyl]piperidine, PSYCHOPHAR, 145(4), 1999, pp. 370-377
Authors:
Kleven, MS
Koek, W
Citation: Ms. Kleven et W. Koek, Effects of different classes of partial benzodiazepine agonists on punished and unpunished responding in pigeons, PSYCHOPHAR, 144(4), 1999, pp. 405-410
Authors:
Prinssen, EPM
Kleven, MS
Koek, W
Citation: Epm. Prinssen et al., Interactions between neuroleptics and 5-HT1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects, PSYCHOPHAR, 144(1), 1999, pp. 20-29
Authors:
Prinssen, EPM
Koek, W
Vignon, J
Kamenka, JM
Kleven, MS
Citation: Epm. Prinssen et al., Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine induced locomotion?, PSYCHOPHAR, 143(1), 1999, pp. 8-14
Authors:
Kleven, MS
Koek, W
Citation: Ms. Kleven et W. Koek, Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans, PSYCHOPHAR, 141(2), 1999, pp. 206-212
Authors:
Slot, LAB
Koek, W
Colpaert, FC
Citation: Lab. Slot et al., Ethanol state dependence involving a lever press response requirement in rats, BEHAV PHARM, 10(2), 1999, pp. 229-233
Authors:
Koek, W
Citation: W. Koek, N-methyl-D-aspartate antagonists and drug discrimination, PHARM BIO B, 64(2), 1999, pp. 275-281
Authors:
John, GW
Pauwels, PJ
Perez, M
Halazy, S
Le Grand, B
Verscheure, Y
Valentin, JP
Palmier, C
Wurch, T
Chopin, P
Marien, M
Kleven, MS
Koek, W
Assie, MB
Carilla-Durand, E
Tarayre, JP
Colpaert, FC
Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95
Authors:
Vacher, B
Bonnaud, B
Funes, P
Jubault, N
Koek, W
Assie, MB
Cosi, C
Kleven, M
Citation: B. Vacher et al., Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors, J MED CHEM, 42(9), 1999, pp. 1648-1660
Authors:
Assie, MB
Cosi, C
Koek, W
Citation: Mb. Assie et al., Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity, EUR J PHARM, 386(1), 1999, pp. 97-103
Authors:
Vacher, B
Bonnaud, B
Funes, P
Jubault, N
Koek, W
Assie, MB
Cosi, C
Citation: B. Vacher et al., Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors, J MED CHEM, 41(25), 1998, pp. 5070-5083
Authors:
Prinssen, EPM
Koek, W
Kleven, MS
Citation: Epm. Prinssen et al., Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907 (vol 355, pg 19, 1998), EUR J PHARM, 361(2-3), 1998, pp. 321-321
Risultati:
1-24
|